| mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.002 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.002 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.005 |